CDSCO panel gives nod for continuation of phase-II clinical trial of SII's dengue vaccine

An expert committee recommended continuation of phase-II clinical trial of Serum Institute of India's vaccine against dengue after successful phase-I interim trial in Australia. The SEC recommendations were made on May 31.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/AavbBMz
via IFTTT